WuXi Biologics is the manufacturing partner of InflaRx for Gohibic (vilobelimab), a first-in-class monoclonal anti-C5a antibody. InflaRx received emerge...
"Parse showed a leap-and-a-point significant progress in the past year, and the market demand for the company's Evercode single-cell sequencing solution ha...
$3,000,000,000 aggregate principal amount of 4.650% Notes due 2025 $3,000,000,000 aggregate principal amount of 4.450% Notes due 2026 $4,000,000,000 aggr...
Ontotext, a trusted partner for many years for top 10 pharmaceutical companies, biotech startups and healthcare enterprises, announces the immediate availa...
SonoThera and Janssen Pharmaceuticals, Inc. have entered into a research collaboration agreement to develop a novel approach for deli...
GE HealthCare (Nasdaq: GEHC) is presenting three new global innovations – Intelligent Radiation Therapy (iRT), Auto Segmentation, and an updated Magn...
"Hot flashes as a result of menopause can be a serious physical burden on women and impact their quality of life," said Janet Maynard, M.D., M.H.S., direct...
NRC Health has been selected by UCHealth to be its partner in building Human Understanding through personalized healthcare solutions and data-driven i...
Under the terms of the agreement, Aligos and Amoytop will collaborate on the research and development of oligonucleotide compounds for the treatment of liv...
Once issued, the patent maturing from this allowed patent application is expected to expire no earlier than February 2039. The allowed claims cover MN...
The co-development of healthPrecision's Medical Brain artificial intelligence (AI) platform at BayCare will be the first time the technology has been a...
Phase II dose-finding trial met primary endpoint after 46 weeks of treatment, representing an important advancement of Boehringer Ingelheim’s cardi...
Collaboration will leverage Bicycle Therapeutic’s synthetic peptides for the discovery and development of multiple targeted radioconjugates of the ...
Recently completed first cohort in Phase 1b/2 trial evaluating Annamycin in combination with cytarabine (Ara-C) for the treatment of acute myeloid leukemia...
© 2025 Biopharma Boardroom. All Rights Reserved.
